We advise to exercise VentriPoint Diagnostics fundamental analysis to find out if markets are presently mispricing the firm. In other words this technique allows you to confirm available indicators of VentriPoint Diagnostics as well as the relationship between them. We were able to interpolate twenty-nine available drivers for VentriPoint Diagnostics, which can be compared to its competition. The stock experiences a very speculative upward sentiment. Check odds of VentriPoint Diagnostics to be traded at C$0.2375 in 90 days. Key indicators impacting VentriPoint Diagnostics' financial strength include:
Please note, the imprecision that can be found in VentriPoint Diagnostics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of VentriPoint Diagnostics. Check VentriPoint Diagnostics' Beneish M Score to see the likelihood of VentriPoint Diagnostics' management manipulating its earnings.
VentriPoint Diagnostics Stock Summary
VentriPoint Diagnostics competes with Reliq Health. Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease primarily in Canada, the United States, and Europe. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart diseases, left or right heart failure, and normal hearts. VENTRIPOINT DIAGNOSTICS operates under Diagnostics Research classification in Canada and is traded on TSX Venture Exchange.
You should never invest in VentriPoint Diagnostics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of VentriPoint Stock, because this is throwing your money away. Analyzing the key information contained in VentriPoint Diagnostics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
VentriPoint Diagnostics Key Financial Ratios
There are many critical financial ratios that VentriPoint Diagnostics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that VentriPoint Diagnostics reports annually and quarterly.
Comparative valuation techniques use various fundamental indicators to help in determining VentriPoint Diagnostics's current stock value. Our valuation model uses many indicators to compare VentriPoint Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VentriPoint Diagnostics competition to find correlations between indicators driving VentriPoint Diagnostics's intrinsic value. More Info.
VentriPoint Diagnostics is rated second in return on equity category among its peers. It is rated second in return on asset category among its peers . At this time, VentriPoint Diagnostics' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VentriPoint Diagnostics' earnings, one of the primary drivers of an investment's value.
VentriPoint Diagnostics Systematic Risk
VentriPoint Diagnostics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. VentriPoint Diagnostics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on VentriPoint Diagnostics correlated with the market. If Beta is less than 0 VentriPoint Diagnostics generally moves in the opposite direction as compared to the market. If VentriPoint Diagnostics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one VentriPoint Diagnostics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of VentriPoint Diagnostics is generally in the same direction as the market. If Beta > 1 VentriPoint Diagnostics moves generally in the same direction as, but more than the movement of the benchmark.
VentriPoint Diagnostics Total Assets Over Time
Today, most investors in VentriPoint Diagnostics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various VentriPoint Diagnostics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of VentriPoint Diagnostics growth as a starting point in their analysis.
VentriPoint Diagnostics March 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of VentriPoint Diagnostics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of VentriPoint Diagnostics. We use our internally-developed statistical techniques to arrive at the intrinsic value of VentriPoint Diagnostics based on widely used predictive technical indicators. In general, we focus on analyzing VentriPoint Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build VentriPoint Diagnostics's daily price indicators and compare them against related drivers.
When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.